Chapin Davis, Inc. Mesoblast LTD Transaction History

Chapin Davis, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 30, 2023	BUY	$2.95 - $4.44 $5,900 - $8,880	2,000 Added 13.33%	17,000 $66.5 Million
Q4 2022 Jan 27, 2023	BUY	$2.73 - $3.7 $40,950 - $55,500	15,000 New	15,000 $43.7 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Chapin Davis, Inc., based on Form 13F filings with the SEC.

Stay updated on Chapin Davis, Inc. with notifications on news.